CUTANEOUS T-CELL LYMPHOMA: New Immunomodulators
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Dermatologic Clinics
- Vol. 19 (4) , 737-748
- https://doi.org/10.1016/s0733-8635(05)70312-0
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignanciesEuropean Journal Of Cancer, 1997
- Suppression of Anti-Interferon -2a Antibody Formation in Patients With Mycosis Fungoides by Exposure to Long-Wave UV Radiation in the A Range and Methoxsalen IngestionJNCI Journal of the National Cancer Institute, 1992
- Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoidsJournal of the American Academy of Dermatology, 1991
- Interferon alpha‐2a in cutaneous T‐cell lymphomaEuropean Journal of Haematology, 1990
- Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Interferon alfa-2a in the treatment of cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon AntibodiesNew England Journal of Medicine, 1988
- Intralesional interferon in the treatment of early mycosis fungoidesJournal of the American Academy of Dermatology, 1985
- Effects of Retinoids on Human Lymphocyte Functions in vitroHuman Toxicology, 1985
- Inhibition of ornithine decarboxylase in human fibroblast cells by type I and type II interferonsBiochemical and Biophysical Research Communications, 1983